Neureads

Neuspera Medical Inc. Raises $23M to Improve Overactive Bladder Treatments They create tiny implantable devices for chronic illnesses like urinary urge incontinence (UUI) caused by overactive bladder (OAB). See what CEO Steffen Hovard says. Swipe left to learn more. Full story: [Link in comments.] Share your story: hi@neureads.com #neurotech #funding #news

Toronto and Los Angeles-based neurotech startup Roga is transforming mental healthcare with its innovative wearable device, designed to combat stress and burnout. 🚀 Roga Raises $1.2M in Pre-Seed Funding! Led by neuroscientist Alison Smith, Ph.D., and former Google product manager Ami Lebendiker, Roga has secured $1.7M CAD ($1.2M USD) to launch its next-generation device this fall. Follow Neureads for the latest updates on neurotechnology! Link: https://lnkd.in/gRAvj-yA #neurotech #mentalhealth #startup #funding

Sinaptica Therapeutics has shared research in Alzheimer's Research & Therapy, showcasing their innovative neuromodulation therapy. This therapy, which is non-invasive, focuses on the Default Mode Network (DMN), a key area for memory, using advanced rTMS-EEG technology. Named "nDMN," the treatment aims to maintain brain structure and improve connectivity. Dr. Giacomo Koch, Sinaptica’s co-founder, highlighted this groundbreaking study as the first of its kind, suggesting it could slow brain atrophy and enhance network connections. Ken Mariash confirmed that these results are consistent with earlier trials, which showed slowed disease progression and no serious side effects. Swipe ⬅️ Full Story: [see comments] Subscribe to Neureads for more updates!

FDA Gives Green Light to CorTec's BCI System for Stroke Rehabilitation Study! CorTec's closed-loop brain-computer interface (BCI) system has just been approved by the FDA for a clinical study on stroke rehabilitation. This breakthrough technology aims to enhance brain plasticity, potentially revolutionizing treatment outcomes. Stay tuned for more updates! 🧠🔄 #neurotech #fda Martin Schuettler

Neurable Secures $13M for Platform Expansion! 💰 So, what's the plan for all that cash? Neurable's directing it straight into beefing up its platform, particularly its BCI technology. But wait, what exactly are they expanding? Swipe for the full story. Dr. Ramses Alcaide, Neurable's CEO, is hyped about democratizing neurotech. Plus, he's excited about the potential of their BCI tech, envisioning it seamlessly integrated into healthcare and our daily routines. Follow Neureads for more updates and subscribe to our newsletter! 🚀 Hastags: [#neurotech #braincomputerinterface #healthtech #startup #funding #technology #news #bci]

Researchers from the University of Cambridge have created flexible nerve cuffs, revolutionizing neurocare. These cuffs wrap around nerves without damage, offering safer diagnostics and treatments. With minimal electricity, they hold the potential to revolutionize patient care. [Swipe for full story] Follow Neureads for more updates. #neurocare #medicalinnovation #nervecuffs #healthtech #research #neuroscience #medicaltechnology #neurologicaldisorders

Tether's $200 Million Investment in Blackrock Neurotech. Tether's recent $200 million investment in Blackrock Neurotech marks a significant milestone in the advancement of brain-computer interface technology. This investment is poised to accelerate the commercialization of Blackrock's neural implants, enhancing computer and prosthetic control for individuals with neurological conditions. Why this matters: Tether recognizes the transformative capabilities of Blackrock's technology, aiming to push the boundaries of neurotechnology. ✅This partnership underscores a shared commitment to fostering innovation and improving healthcare through groundbreaking advancements in brain-computer interfaces. Swipe for the full story👉 Follow Neureads for more insightful content on neurotech and related topics. hastags: [#neurotech #braincomputerinterface #investment #innovation #healthcare #technology #blackrockneurotech #tether #partnership]

TMS to Modulate Heart Rate and Treat Depression A study has uncovered a common brain network linking heart rate and depression. By stimulating specific brain regions associated with depression, corresponding changes in heart rate were observed. This discovery suggests that heart rate could serve as a guiding tool for precise brain stimulation in depression treatment. Swipe for the full story. Follow Neureads for more updates. Hastags: [#depression #brainstimulation #hearthealth #tms #research #neurotech #neuroscience #news #brain #biomedical]

iVEAcare, Inc. has secured a $27.5 million Series A. Led by Vensana Capital, with participation from Treo Ventures and other notable investors. This investment is a turning point for iVEAcare as it strives to advance innovative neuromodulation therapy, enhancing patient care. swipe for full story. Follow Neureads for more. hashtags [#neuromodulation #healthtech #seriesafunding #medicalinnovation #healthcare #startupnews #neurotech #neuroscience ]

UNESCO's Neuroethics Initiative! UNESCO has assembled a diverse team of 24 global experts to pioneer the world's first ethics framework for neurotechnology. Why is this important? ✅ Neurotechnology holds immense potential in treating neurological disorders, but its unregulated development poses risks to human rights and freedoms. ✅ Commercial neurotech devices can harvest neural data, raising concerns about privacy and misuse of information. ✅ UNESCO's ethical framework aims to ensure that the use of neurotechnologies aligns with fundamental human rights. Hashtags: #neuroethics #unesco #ethicstech #globalcollaboration #neurotech #humanrights #privacy #innovation #ethicalframework #news